Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
Hostname: page-component-ffbbcc459-kwkjh Total loading time: 0.158 Render date: 2022-03-03T20:57:41.009Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }
  • English
Infection Control & Hospital Epidemiology Infection Control & Hospital Epidemiology

Article contents

Inactivation of Human Immunodeficiency Virus by Betadine

Published online by Cambridge University Press:  02 January 2015

Joan C. Kaplan ,
David C. Crawford ,
Amy G. Durno  and
Robert T. Schooley
Joan C. Kaplan*
Affiliation:
Infectious Disease Unit, Massachusetts General Hospital, Boston, Massachusetts
David C. Crawford
Affiliation:
Infectious Disease Unit, Massachusetts General Hospital, Boston, Massachusetts
Amy G. Durno
Affiliation:
Infectious Disease Unit, Massachusetts General Hospital, Boston, Massachusetts
Robert T. Schooley
Affiliation:
Infectious Disease Unit, Massachusetts General Hospital, Boston, Massachusetts
*
Infectious Disease Unit, Massachusetts General Hospital, Boston, MA 02114
Get access Rights & Permissions[Opens in a new window]

Abstract

Human immunodeficiency virus (HIV), the etiological agent of the acquired immunodeficiency syndrome (AIDS), was treated with either Betadine® (povidone-iodine) Solution or Betadine Surgical Scrub®. HIV inactivation was analyzed using the viral reverse transcriptase assay or by observing the cytopathic effect produced in HIV-infected, H-9, T-cell cultures. The minimum effective Betadine dose was 0.25% for complete inactivation of HIV that was treated for various time intervals (immediate vortex to ten minutes). The titer of HIV stocks used in these experiments (105 TCID50 per mL) was greater than amounts generally detected in clinical specimens. Our results provide a rationale for the use of povidone-iodine as a topical antiseptic against HIV in the clinic or laboratory.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 8 , Issue 10 , October 1987 , pp. 412 - 414
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1987

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Barre-Sinoussi, F, Chermann, JC, Rey, F, et al: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868–871.CrossRefGoogle Scholar
2. Gallo, RC, Salahuddin, SZ, Popovic, M, et al: Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984;224:500–503.CrossRefGoogle Scholar
3. Barns, DM, Grim projections for AIDS epidemic. Science 1986;232:1589–1590.CrossRefGoogle Scholar
4. Curran, JW, Morgan, WM, Hardy, AM, et al: The epidemiology of AIDS, Current status and future prospects. Science 1985;229:1352–1357.CrossRefGoogle ScholarPubMed
5. Ho, DD, Schooley, RT, Rota, TR, et al: HTLV-III in the semen and blood of a healthy homosexual man. Science 1984;226:451–453.CrossRefGoogle ScholarPubMed
6. Ho, DD, Byington, RE, Schooley, RT, et al: Infrequency of isolation of HTLV-III virus from saliva in AIDS. N Engl J Med 1985;313:1606.Google Scholar
7. Ho, DD, Rota, TR, Schooley, RT, et al: Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurological syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313:1493–1497.CrossRefGoogle Scholar
8. Fujikawa, LS, Salahuddin, SZ, Palestine, AG, Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet 1985;ii:529–530.CrossRefGoogle Scholar
9. Klatzmann, D, Barre-Sinoussi, F, Nugeyre, MT, et al: Selective tropism of lymph-adenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 1984;225:59–64.CrossRefGoogle Scholar
10. Popovic, M, Sarngadharan, MG, Read, E, et al: Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984;224:497–500.CrossRefGoogle ScholarPubMed
11. Spire, B, Barre-Sinoussi, F, Montagnier, L, et al: Inactivation of lymphadenop-athy associated virus by chemical disinfectants. Lancet 1984;i:898–901.Google Scholar
12. Resnick, L, Veren, K, Salahuddin, SZ, et al: Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 1986;225:1887–1891.CrossRefGoogle Scholar
13. Berkelman, RL, Holland, BW, Anderson, RL, Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol 1982;15:635–639.Google ScholarPubMed
14. Poiescz, BW, Ruscetti, FW, Gasdar, AF, et al: Isolation of type-C retrovirus particles from cultured human T-lymphocytic cell lines. Proc Natl Acad Sci USA 1980;77:7415–7419.CrossRefGoogle Scholar
15. Martin, LS, McDonegal, JS, Loskoski, SL, Disinfection and inactivation of the human T-lymphotropic virus type III/lymphadenopathy-associated virus. J Infect Dis 1985;152:400–402.CrossRefGoogle ScholarPubMed
27
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Inactivation of Human Immunodeficiency Virus by Betadine
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Inactivation of Human Immunodeficiency Virus by Betadine
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Inactivation of Human Immunodeficiency Virus by Betadine
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *